Results 81 to 90 of about 50,724 (271)

Reoperative aortic valve replacement in the era of valve‐in‐valve procedures

open access: yesClinical Case Reports, 2020
Current evidence suggests that the choice between valve‐in‐valve transcatheter aortic valve implantation and reoperative aortic valve replacement should be based on multiple factors.
Daisuke Kaneyuki   +3 more
doaj   +1 more source

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes [PDF]

open access: yes, 2017
Background: Transcarotid access is an alternative route for transcutaneous aortic valve implantation (TAVI) in patients with impossible transfemoral access.Aims: We evaluated the safety, effectiveness and early and late clinical outcomes of CoreValve®
Berger, Alexandre   +10 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Cost effectiveness of aortic valve therapies: a systematic review of the literature

open access: yesEpidemiology, Biostatistics and Public Health, 2013
Background: we performed a systematic review on the cost effectiveness of transcatheter aortic valve implantation (TAVI) to standard aortic valve replacement and medical management in high-risk elderly patients with severe aortic stenosis.Methods: in ...
Suzanne Battaglia   +2 more
doaj   +1 more source

In vitro haemodynamic testing of Amplatzer plugs for paravalvular leak occlusion after Transcather Aortic Valve Implantation [PDF]

open access: yes, 2016
Objective: We aimed to in-vitro test Amplatzer devices (Amplatzer Vascular Plug II and Amplatzer Vascular Plug III, SJM St. Paul, MN) in closing PVL generated by transcatheter balloon expandable aortic valve prosthesis in order to quantify the effective ...
Burriesci, G   +4 more
core  

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Neurological Complications after Transcatheter Aortic Valve Implantation Procedure

open access: yesPielęgniarstwo Neurologiczne i Neurochirurgiczne
Aortic stenosis is the most common primary valvular heart disease in both Europe and North America. In patients with symptomatic severe aortic stenosis, early surgical treatment is recommended because of the very poor prognosis and the lack of effect of ...
Daniel Rogowicz   +7 more
doaj   +1 more source

Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study [PDF]

open access: yes, 2011
Background Before trans-catheter aortic valve implantation (TAVI), assessment of cardiac function and accurate measurement of the aortic root are key to determine the correct size and type of the prosthesis.
Alessio La Manna   +13 more
core   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Transcatheter aortic-valve implantation

open access: yes, 2022
The aim of this thesis is to provide an overview of the evolution of TAVI in the ErasmusMC since the first procedure in 2005, the implementation of the TAVI Care and CureProgram and the consequences on daily clinical practice. Central to this is the holisticapproach to the individual patient with Aortic Valve stenosis, to determine the besttreatment ...
openaire   +4 more sources

Home - About - Disclaimer - Privacy